Get it on Google Play

PDL BioPharma (PDLI) and Orphan Therapeutics End Terlipressin Agreement

December 19, 2006 7:53 AM EST Send to a Friend
PDL BioPharma, Inc. (Nasdaq: PDLI) said following a meeting among representatives of the Food and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login